Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

PFEJNJ

Area by area

Overall Quant Score

How does it look overall? (out of 100)

PFE

49/100

JNJ

62/100

Quality

Is it a profitable, well-run business?

PFE

4.2/10

JNJ

6.5/10

Growth

Is the company growing?

PFE

2.4/10

JNJ

5.3/10

Valuation

Is the price reasonable? (higher = cheaper)

PFE

7.3/10

JNJ

5.7/10

Risk

How risky are the shares? (higher = lower risk)

PFE

6.7/10

JNJ

9.1/10

Momentum

Is the share price trending up?

PFE

8.4/10

JNJ

8.4/10

Financial strength

Is the balance sheet healthy?

PFE

3.9/10

JNJ

7.2/10

The balanced view

Model-generated

Pfizer Inc.

This company has a mixed profile, with a positive price trend and a reasonable valuation, although its growth has been slow.

Leads on: valuation

Best feature: positive price trend (Trend alignment (50/200 SMA): 3/3)

Watch out: growth is slow or negative (Revenue CAGR (3Y): -14.8%)

Johnson & Johnson

This company scores above average, with a relatively low-risk profile and a positive price trend, although analysts are cautious.

Leads on: quality, growth, risk, momentum, financial strength

Best feature: relatively low risk (Beta (vs. market): 0.23)

Watch out: analysts are cautious (Target upside: 8.1%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.